- Home
- WAVE vs IGC Comparison
WAVE vs IGC Comparison
Compare WAVE & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- IGC
- Stock Information
- Founded
- WAVE 2011
- IGC 2005
- Country
- WAVE Israel
- IGC United States
- Employees
- WAVE N/A
- IGC N/A
- Industry
- WAVE Electric Utilities: Central
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- WAVE Utilities
- IGC Health Care
- Exchange
- WAVE Nasdaq
- IGC Nasdaq
- Market Cap
- WAVE 46.0M
- IGC 39.8M
- IPO Year
- WAVE 2021
- IGC N/A
- Fundamental
- Price
- WAVE $8.22
- IGC $0.40
- Analyst Decision
- WAVE Strong Buy
- IGC Strong Buy
- Analyst Count
- WAVE 1
- IGC 2
- Target Price
- WAVE $15.00
- IGC $4.00
- AVG Volume (30 Days)
- WAVE 26.9K
- IGC 757.9K
- Earning Date
- WAVE 11-20-2025
- IGC 11-11-2025
- Dividend Yield
- WAVE N/A
- IGC N/A
- EPS Growth
- WAVE N/A
- IGC N/A
- EPS
- WAVE N/A
- IGC N/A
- Revenue
- WAVE $168,000.00
- IGC $1,327,000.00
- Revenue This Year
- WAVE $325.00
- IGC $3.54
- Revenue Next Year
- WAVE $85.71
- IGC $15.12
- P/E Ratio
- WAVE N/A
- IGC N/A
- Revenue Growth
- WAVE N/A
- IGC 24.95
- 52 Week Low
- WAVE $4.41
- IGC $0.25
- 52 Week High
- WAVE $17.63
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- WAVE 49.66
- IGC 46.88
- Support Level
- WAVE $7.90
- IGC $0.38
- Resistance Level
- WAVE $8.60
- IGC $0.43
- Average True Range (ATR)
- WAVE 0.47
- IGC 0.02
- MACD
- WAVE -0.03
- IGC -0.00
- Stochastic Oscillator
- WAVE 59.02
- IGC 29.83
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.